Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 48,082 | 47,734 | 43,066 | 33,312 | 31,060 |
| Operating Income | -46,803 | -47,734 | -43,066 | -33,312 | -31,060 |
| Interest Expense | 1,596 | 775 | 160 | 133 | 655 |
| Other Income | 436 | 0 | 0 | 0 | 473 |
| Pre-tax Income | -47,963 | -48,509 | -43,226 | -33,445 | -31,242 |
| Net Income Continuous | -47,963 | -48,509 | -43,226 | -33,445 | -31,242 |
| Net Income | $-47,963 | $-48,509 | $-43,226 | $-33,445 | $-31,242 |
| EPS Basic Total Ops | -1.23 | -1.24 | -1.17 | -0.92 | -0.88 |
| EPS Basic Continuous Ops | -1.24 | -1.24 | -1.17 | -0.92 | -0.87 |
| EPS Diluted Total Ops | -1.23 | -1.24 | -1.17 | -0.92 | -0.88 |
| EPS Diluted Continuous Ops | -1.24 | -1.24 | -1.17 | -0.92 | -0.87 |
| EBITDA(a) | $-47,542 | $-47,233 | $-42,594 | $-32,763 | $-30,574 |